Cholera Crisis Escalates in DRC

The Democratic Republic of the Congo (DRC) is apparently grappling with its most severe cholera outbreak in recent years. With over 38,000 cases and 951 deaths in July alone, the situation is dire, especially for children under five, who account for over 25% of the cases. Provinces like South Kivu, North Kivu, and Tanganyika are high-risk areas due to limited access to sanitation and clean water. The capital city, Kinshasa, reports a case fatality rate of 8%, raising fears of a health crisis. Floods, mass displacement, and inadequate health infrastructure exacerbate the problem, necessitating immediate international assistance. Emergency responses are underway, but the DRC’s insufficient resources call for substantial support to prevent cross-border transmission and secure the region’s future health. All this I just read is from UNICEF. But where the United Nations is involved, it immediately necessitates that we take a closer look.
Sudan Health Ministry Reports Over 1,300 New Cholera Cases in One Week
the Sudanese Health Ministry reported that from July 12-18, a total of 18 people died across Sudan due to this deadly disease spread via contaminated water. Over 91,000 cases since July 2024, a total of 2,302 deaths and infections recorded in 17 out of 18 states. Interestingly, the report then goes on to say that cholera cases in the Khartoum State are declining following a ten-day vaccination campaign, with 2.24 million people vaccinated (96% coverage). This was the report given by the WHO, stating that new cases dropped from 1,500 to 10-11 per day. Let’s quickly resolve the claims by the WHO.
Zimbabwe door-to-door cholera vaccination campaign
Zimbabwe launched a cholera vaccination campaign to immunize over 2 million people against the waterborne disease, amid an outbreak that has killed hundreds since early 2023. In response to the cholera update, the government implemented an oral cholera vaccination programme, aiming to inoculate over 2.3 million people. The single-shot OCV provides six months of protection against the diarrhoeal illness. So, boosters? But now, they are being used as a poster child for other countries to follow suit.
Mass cholera vaccination carried out in Southern Africa
SADC urged Member States to jointly plan and implement synchronised cross border vaccination campaigns against Cholera, if necessary, and mobilise vaccines for affected and non-affected countries at risk. The organization also devoted to “increase investment in the current cholera emergency response” and “accelerate local and regional manufacturing of cholera vaccines” among other measures. Cholera outbreaks had been reported in several SADC countries, most notably Zambia, Zimbabwe, Malawi, Mozambique and Tanzania. In Mozambique alone, they rolled out a target to vaccinate over 2 million people against cholera. Kenya has also been running a much-celebrated Vaccine campaign. 72% Increase in Cholera Vaccine Revenues, If I’m talking about it, it means there is money involved.
The cost to immunize against cholera is between US$0.10 and US$4.00 per vaccination. The Vaxchora vaccine can cost more than US$250. Since the beginning of 2023, there have been 24 reactive cholera vaccination campaigns implemented in 12 countries. But, there is a global shortage of cholera vaccines. From January 2023 to January 2024, 76 million oral cholera vaccines (OCV) were requested by 14 countries, while only 38 million doses were available. The World Health Organization (WHO) has three pre-qualified OCVs: Dukoral®, Shanchol™, and Euvichol®. One of these OCV manufacturers reported a 72% increase in revenues today. On February 15, 2024, Valneva SE reported its revenue for 2023. Last year, sales of Valneav’s DUKORAL® vaccine amounted to €29.8 million (US32 million), a significant increase from the €17.3 million recorded in 2022. This significant increase can be attributed to the recovery of the private travel markets and price hikes. In a press release, Peter Bühler, Valneva’s Chief Financial Officer, commented, “In 2023, Valneva successfully executed key strategic objectives despite a difficult economic environment…. we are entering 2024 in a good financial position to support our commercial and R&D objectives.” It’s a money-making gimmick for some, fuelled by something deeper and darker. The depopulation agenda.
EuBiologics main supplier of cholera vaccine to global vaccine stockpile
The Oral Cholera Vaccine was developed with the support from the Bill & Melinda Gates Foundation through the International Vaccine Institute. This vaccine technology was then transferred to a South Korean Company EuBiologics, which is mass producing the Euvichol oral cholera vaccine. This vaccine was introduced in Haiti and Malawi as well as in other African countries. The WHO then pre-qualified this cholera vaccine and is now the only oral cholera vaccine available for mass vaccination campaigns. Why? Surprisingly, the other prequalified oral cholera vaccine Shanchol was discontinued and production stopped amidst cholera outbreaks. Coincidentally, Sanofi stopped producing the Shanchol vaccine citing less demand for cholera vaccines. Yet as soon as that happens and the Gates invested Euvichol is the only vaccine in the market the demand for cholera vaccines shoots sky high! Currently EuBiologics is the main supplier of the cholera vaccine to the global vaccine stockpile and Euvichol-Plus is the primary product in use.
Revelations about unnecessary and experimental vaccination
Notice the similarities between the vaccines that have been covered. The Oral Cholera Vaccine and the Oral Polio Vaccine have one manufacturer that Gates has invested in, and they become the main or sole supplier of the vaccine globally. In 2022, A European Parliamentary Question asked whether the European Commission had investigated the disturbing revelations about the unnecessary and experimental vaccination of the Haitian people organized by the Bill & Melinda Gates Foundation (BMGF). What disturbing revelations? World renowned expert on cholera, Professor Renaud Piarroux, exposed that the Bill & Melinda Gates Foundation organized a large-scale trial of the single-dose vaccine using bogus publications and modelling, without clarifying that cholera had disappeared in Haiti two years earlier. The aim of the mass vaccination campaign was to gain support and create a market for the oral cholera vaccine, since Bill Gates owns cholera vaccine factories in South Korea. This vaccine trial in Haiti had been supported as a joint investment between BMGF and with the European Commission (EC) committing close to EUR10 million. Additionally, the European Commission was jointly investing close to EUR100 million in ‘health in Africa’ with the BMGF. The European Parliament questioned why the joint investment (BMGF and EC) was happening despite Microsoft laying off 25,000 European workers, and with the claims that these experimental vaccinations were not necessary.
They always seem to have the money to give people poisonous vaccines but Not Clean Water… Don’t take their poison chemicals. Have you learned nothing? The people who seek to exterminate you … cannot give you healing. How do the African people not know that they have been test subjects for vaccines since Gates and company came along?
The WHO is a criminal racketeering organisation
As explained by Dr. David Martin, the WHO is a “criminal racketeering organisation”—founded by eugenicists—which has been, since 1953, “exclusively a vaccine promoting enterprise, for the benefit of the people who have a commercial interest in vaccines”. The minute the people who have a financial incentive to gain from the decision to declare a pandemic, the minute they’re the ones who are collecting data… they’re going to collect the data that actually justifies their existence. As long as the financial interest that dictates what product is going to be promoted is the one making the declaration of the pandemic, we have no possibility for accountability.
Namibia’s New Surveillance Strategy: A Leap Toward Better Health Security
Namibia has made a significant stride in public health surveillance by launching the Event-Based Surveillance (EBS) Guideline in Windhoek. This move aims to foster early detection and rapid response to health threats such as malaria and cholera, integrating information from diverse sectors for comprehensive monitoring. Supported by the Africa CDC and WHO, Namibia’s approach tailors public health solutions to its unique challenges, bolstering its capacity to manage acute health risks. This initiative comes at a time, coinciding with ongoing outbreaks in the region. With the third edition of the Integrated Disease Surveillance and Response (IDSR) strategy enhancing information flow from local to national levels, Namibia is reinforcing its ability to protect public health. The adoption of these guidelines aligns with continental efforts to strengthen public health systems and is a step toward improving epidemic intelligence across Africa.
Written By Lindokuhle Mabaso